BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2652378)

  • 1. Mutagenicity of cisplatin and carboplatin used alone and in combination with four other anticancer drugs.
    Hannan MA; al-Dakan AA; Hussain SS; Amer MH
    Toxicology; 1989 Apr; 55(1-2):183-91. PubMed ID: 2652378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of cisplatin and carboplatin used alone and in combination with the other anticancer drugs in the mouse embryo C3H10T1/2 cell line.
    Hussain SS; Amer MH; Hannan MA
    Chemotherapy; 1988; 34(6):504-11. PubMed ID: 2468457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity studies of methyl-tert-butylether using the Ames tester strain TA102.
    Williams-Hill D; Spears CP; Prakash S; Olah GA; Shamma T; Moin T; Kim LY; Hill CK
    Mutat Res; 1999 Oct; 446(1):15-21. PubMed ID: 10613182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenic potential of Mancozeb in Salmonella typhimurium.
    Shukla Y; Taneja P; Arora A; Sinha N
    J Environ Pathol Toxicol Oncol; 2004; 23(4):297-302. PubMed ID: 15511217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of mutagenic and antimutagenic activities of fluoride in Ames salmonella assays.
    Li Y; Dunipace AJ; Stookey GK
    Mutat Res; 1987 Apr; 190(4):229-36. PubMed ID: 3550448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of oxidative mutagens in an urban air-particulate extract: a preliminary study.
    Hoyer ME; Keeler GJ; Ball JC
    Mutat Res; 1992 Dec; 283(4):295-9. PubMed ID: 1383803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity and clastogenicity evaluation of tacrine by Ames and micronucleus assays.
    Mulla MS; Vedamurthy RB; Jana S; Pandey SK; Goyal VK; Nirogi R
    Drug Chem Toxicol; 2012 Oct; 35(4):366-70. PubMed ID: 22182316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of the physicochemical and pharmacological properties of anticancer platinum compounds by commercial 5-fluorouracil formulations: a comparative study using cisplatin and carboplatin.
    Fournier C; Hecquet B; Bastian G; Khayat D
    Cancer Chemother Pharmacol; 1992; 29(6):461-6. PubMed ID: 1568289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous revertants in modified S. typhimurium mutagenicity tests employing elevated numbers of the tester strain.
    Georghiou PE; Blagden PA; Winsor L; Williams DT
    Mutat Res; 1989; 225(1-2):33-9. PubMed ID: 2643768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenicity studies with nitrofurans. II. mutagenicity of nitrofurylacrylic acid for Salmonella typhimurium.
    Cerná M; Srám RJ
    Mutat Res; 1980 Jan; 77(1):1-12. PubMed ID: 6987507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial mutagenicity assays: Vehicle and positive control results from the standard Ames assay, the 6- and 24-well miniaturized plate incorporation assays and the Ames II™ assay.
    Pant K; Bruce S; Sly J; Klug Laforce M; Springer S; Cecil M; Andrus E; Dakoulas E; Wagner VO; Hewitt NJ; Kulkarni R
    Environ Mol Mutagen; 2016 Jul; 57(6):483-96. PubMed ID: 27198925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of culture conditions on the susceptibility of Salmonella typhimurium in the Salmonella mutagenicity test.
    Mersch-Sundermann V; Krämer H
    Zentralbl Hyg Umweltmed; 1993 Feb; 193(5):471-80. PubMed ID: 8476499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen peroxide mutagenicity towards Salmonella typhimurium.
    Kensese SM; Smith LL
    Teratog Carcinog Mutagen; 1989; 9(4):211-8. PubMed ID: 2572065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity of alkylhydrazine oxalates in Salmonella typhimurium TA100 and TA102 demonstrated by modifying the growth conditions of the bacteria.
    Matsushita H; Endo O; Matsushita H; Yamamoto M; Mochizuki M
    Mutat Res; 1993 Apr; 301(4):213-22. PubMed ID: 7680754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and classification of mutagens: a set of base-specific Salmonella tester strains.
    Gee P; Maron DM; Ames BN
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11606-10. PubMed ID: 7972111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum compounds in the treatment of advanced breast cancer.
    Martín M
    Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mutagenicity of mixtures of halogenated aliphatic hydrocarbons and polycyclic aromatic hydrocarbons in the Ames test with TA98 and TA100].
    Kevekordes S; Porzig J; Gebel T; Dunkelberg H
    Zentralbl Hyg Umweltmed; 1998 Feb; 200(5-6):531-41. PubMed ID: 9531725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxidative activation of 3,3'-dichlorobenzidine to mutagenic products in the Salmonella typhimurium test.
    Lang B; Iba MM
    Mutat Res; 1987; 191(3-4):139-43. PubMed ID: 3306365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Salmonella typhimurium TA102 with Escherichia coli WP2 tester strains.
    Wilcox P; Naidoo A; Wedd DJ; Gatehouse DG
    Mutagenesis; 1990 May; 5(3):285-91. PubMed ID: 2200948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity of nitrophenanthrene derivatives for Salmonella typhimurium: effects of nitroreductase and acetyltransferase.
    Sera N; Fukuhara K; Miyata N; Tokiwa H
    Mutat Res; 1996 Jan; 349(1):137-44. PubMed ID: 8569786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.